A collection of news and information related to Gaucher's Disease published by this site and its partners.
Displaying items 1-3 of 3 » View latimes.com items only
Booster ShotsThe Food and Drug Administration on Friday formally approved a new drug called velaglucerase alfa for injection (tradenamed VPRIV) for treatment of the rare genetic disorder Gaucher disease. The agency has already been allowing the company to ship the...
Los Angeles Times Staff WriterGregory Cochran has always been drawn to puzzles. This one had been gnawing at him for several years: Why are European Jews prone to so many deadly genetic diseases? Tay-Sachs disease. Canavan disease. More than a dozen more. It offended Cochran's sense...
Dozens of brand-name prescription drugs are losing their patent protection, allowing generic versions to enter the market and consumers to save 30 to 80 percent on those medications, said David Belian, director of media relations for the Generic...
Feb 26, 2010 | Los Angeles Times
Apr 18, 2009 |Story| Los Angeles Times
Aug 1, 2012 |Story| Chicago Tribune